Thymoquinone supplementation attenuates cyclophosphamide-induced cardiotoxicity in rats

Journal of Biochemical and Molecular Toxicology

Volumn 25, Issue 3, 2011, Pages 135-142

  Nagi, Mahmoud N ^a   Al Shabanah, Othman A ^a   Hafez, Mohamed M ^a   Sayed Ahmed, Mohamed M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Adenosine Triphosphate; Cardiotoxicity; Cyclophosphamide; Nitrosative Stress; Oxidative Stress; Thymoquinone

Indexed keywords

ADENOSINE TRIPHOSPHATE; CATALASE; CHOLESTEROL; CREATINE KINASE; CREATININE; CYCLOPHOSPHAMIDE; DRINKING WATER; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LACTATE DEHYDROGENASE; NITRATE; NITRITE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID; THYMOQUINONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; CARDIOTOXICITY; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; ENERGY YIELD; HEART; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MITOCHONDRION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; RAT; SERUM; SUPPLEMENTATION; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; WISTAR RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; BENZOQUINONES; CHOLESTEROL; CREATINE KINASE, MB FORM; CREATININE; CYCLOPHOSPHAMIDE; DIETARY SUPPLEMENTS; GLUTATHIONE; HEART DISEASES; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIUM; NITRATES; NITRITES; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; UREA;

ANIMALIA; NIGELLA SATIVA; RATTUS;

EID: 79958783302     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20369     Document Type: Article

References (59)

1. Baumann F, Preiss R. Cyclophosphamide and related anticancer drugs. J Chromatogr B: Biomed Sci Appl 2001;764(1-2):173-192.
2. Murphy SB, Bowman WP, Abromowitch M, Mirro J, Ochs J, Rivera G, Pui CH, Fairclough D, Berard CW. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986;4(12):1732-1739.
3. Bhosle JaH. Principles of cancer treatment by chemotherapy. Surgery 2006;24(2):66-69.
4. Brock N, Pohl J, Stekar J, Scheef W. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention-III, profile of action of sodium 2-mercaptoethane sulfonate (mesna). Eur J Cancer Clin Oncol 1982;18(12):1377-1387.
5. Colvin OM. An overview of cyclophosphamide development and clinical applications. Curr Pharm Des 1999;5(8):555-560.
6. Ludeman SM. The chemistry of the metabolites of cyclophosphamide. Curr Pharm Des 1999;5(8):627-643.
7. Shanholtz C. Acute life-threatening toxicity of cancer treatment. Crit Care Clin 2001;17(3):483-502.
8. Mills BA, Roberts RW. Cyclophosphamide-induced cardiomyopathy: A report of two cases and review of the English literature. Cancer 1979;43(6):2223-2226.
9. Steinherz LJ, Steinherz PG, Mangiacasale D, O'Reilly R, Allen J, Sorell M, Miller DR. Cardiac changes with cyclophosphamide. Med Pediatr Oncol 1981;9(5):417-422.
10. Goldberg MA, Antin JH, Guinan EC, Rappeport JM. Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor. Blood 1986;68(5):1114-1118.
11. Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 1981;141(6):758-763.
12. Mythili Y, Sudharsan PT, Selvakumar E, Varalakshmi P. Protective effect of dl-α-lipoic acid on cyclophosphamide induced oxidative cardiac injury. Chem Biol Interact 2004;151(1):13-19.
13. Loudet AM, Dousset N, Carton M, Douste-Blazy L. Effects of an antimitotic agent (cyclophosphamide) on plasma lipoproteins. Biochem Pharmacol 1984;33(19):2961-2965.
14. Lespine A, Chap H, Perret B. Impaired secretion of heart lipoprotein lipase in cyclophosphamide-treated rabbit. Biochim Biophys Acta 1997;1345(1):77-85.
15. 2+ dependent damage of rat heart and liver mitochondria by cyclosporin A. Comp Biochem Physiol A: Mol Integr Physiol 1998;121(3):209-214.
16. Mythili Y, Sudharsan PT, Varalakshmi P. dl-α-lipoic acid ameliorates cyclophosphamide induced cardiac mitochondrial injury. Toxicology 2005;215(1-2):108-114.
17. Houghton PJ, Zarka R, de las Heras B, Hoult JR. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 1995;61(1):33-36.
18. Nagi MN, Mansour MA. Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol Res 2000;41(3):283-289.
19. Nagi MN, Alam K, Badary OA, Al-Shabanah OA, Al-Sawaf HA, Al-Bekairi AM. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem Mol Biol Int 1999;47(1):153-159.
20. Badary OA, Nagi MN, Al-Shabanah OA, Al-Sawaf HA, Al-Sohaibani MO, Al-Bekairi AM. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can J Physiol Pharmacol 1997;75(12):1356-1361.
21. Mohamed A, Shoker A, Bendjelloul F, Mare A, Alzrigh M, Benghuzzi H, Desin T. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor. Biomed Sci Instrum 2003;39:440-445.
22. Mohamed A, Afridi DM, Garani O, Tucci M. Thymoquinone inhibits the activation of NF-kB in the brain and spinal cord of experimental autoimmune encephalomyelitis. Biomed Sci Instrum 2005;41:388-393.
23. El-Abhar HS, Abdallah DM, Saleh S. Gastroprotective activity of Nigella sativa oil and its constituent, thymoquinone, against gastric mucosal injury induced by ischaemia/reperfusion in rats. J Ethnopharmacol 2003;84(2-3):251-258.
24. Badary OA. Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. J Ethnopharmacol 1999;67(2):135-142.
25. Alenzi FQ, El-Bolkiny Yel S, Salem ML. Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide. Br J Biomed Sci 2010;67(1):20-28.
26. Buhl SN, Jackson KY. Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate-to-lactate reactions in human serum at 25, 30, and 37 °C. Clin Chem 1978;24(5):828-831.
27. Wu AH, Bowers GN Jr. Evaluation and comparison of immunoinhibition and immunoprecipitation methods for differentiating MB and BB from macro forms of creatine kinase isoenzymes in patients and healthy individuals. Clin Chem 1982;28(10):2017-2021.
28. Parekh AC, Caranto M, Mathur RK, Jung DH. Fractionation of serum cholesterol: A critique. Ann Clin Lab Sci 1976;6(5):423-429.
29. Foster LB, Dunn RT. Stable reagents for determination of serum triglycerides by a colorimetric Hantzsch condensation method. Clin Chem 1973;19(3):338-340.
30. Tabacco A, Meiattini F, Moda E, Tarli P. Simplified enzymic/colorimetric serum urea nitrogen determination. Clin Chem 1979;25(2):336-337.
31. Fabiny DL, Ertingshausen G. Automated reaction-rate method for determination of serum creatinine with the CentrifiChem. Clin Chem 1971;17(8):696-700.
32. Wolters G, Kuijpers LP, Kacaki J, Schuurs AH. Enzyme-linked immunosorbent assay for hepatitis B surface antigen. J Infect Dis 1977;136(Suppl.):S311- S317.
33. Davies MH, Birt DF, Schnell RC. Direct enzymatic assay for reduced and oxidized glutathione. J Pharmacol Methods 1984;12(3):191-194.
34. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95(2):351-358.
35. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001;5(1):62-71.
36. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244(22):6049-6055.
37. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976;71(4):952-958.
38. 2). Proc Soc Exp Biol Med 1978:478-481.
39. Botker HE, Kimose HH, Helligso P, Nielsen TT. Analytical evaluation of high energy phosphate determination by high performance liquid chromatography in myocardial tissue. J Mol Cell Cardiol 1994;26(1):41-48.
40. Mythili Y, Sudharsan PT, Amudha G, Varalakshmi P. Effect of dl-α-lipoic acid on cyclophosphamide induced lysosomal changes in oxidative cardiotoxicity. Life Sci 2007;80(21):1993-1998.
41. Sudharsan PT, Mythili Y, Selvakumar E, Varalakshmi P. Lupeol and its ester exhibit protective role against cyclophosphamide-induced cardiac mitochondrial toxicity. J Cardiovasc Pharmacol 2006;47(2):205-210.
42. Fatani AG, Darweesh AQ, Rizwan L, Aleisa AM, Al-Shabanah OA, Sayed-Ahmed MM. Carnitine deficiency aggravates cyclophosphamide-induced cardiotoxicity in rats. Chemotherapy 2010;56(1):71-81.
43. Takami H, Matsuda H, Kuki S, Nishimura M, Kawashima Y, Watari H, Furuya E, Tagawa K. Leakage of cytoplasmic enzymes from rat heart by the stress of cardiac beating after increase in cell membrane fragility by anoxia. Pflugers Arch 1990;416(1-2):144-150.
44. Janero DR, Hreniuk D, Sharif HM. Hydrogen peroxide-induced oxidative stress to the mammalian heart-muscle cell (cardiomyocyte): Lethal peroxidative membrane injury. J Cell Physiol 1991;149(3):347-364.
45. Senthilkumar S, Devaki T, Manohar BM, Babu MS. Effect of squalene on cyclophosphamide-induced toxicity. Clin Chim Acta 2006;364(1-2):335-342.
46. Todorova V, Vanderpool D, Blossom S, Nwokedi E, Hennings L, Mrak R, Klimberg VS. Oral glutamine protects against cyclophosphamide-induced cardiotoxicity in experimental rats through increase of cardiac glutathione. Nutrition 2009;25(7-8):812-817.
47. Nagi MN, Almakki HA. Thymoquinone supplementation induces quinone reductase and glutathione transferase in mice liver: possible role in protection against chemical carcinogenesis and toxicity. Phytother Res 2009;23(9):1295-1298.
48. Mythili Y, Sudharsan PT, Sudhahar V, Varalakshmi P. Protective effect of dl-α-lipoic acid on cyclophosphamide induced hyperlipidemic cardiomyopathy. Eur J Pharmacol 2006;543(1-3):92-96.
49. Bamosa AO, Ali BA, Al-Hawsawi ZA. The effect of thymoquinone on blood lipids in rats. Indian J Physiol Pharmacol 2002;46(2):195-201.
50. Badary OA, Abdel-Naim AB, Abdel-Wahab MH, Hamada FM. The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats. Toxicology 2000;143(3):219-226.
51. Sayed-Ahmed MM, Nagi MN. Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats. Clin Exp Pharmacol Physiol 2007;34(5-6):399-405.
52. El-Mahmoudy A, Matsuyama H, Borgan MA, Shimizu Y, El-Sayed MG, Minamoto N, Takewaki T. Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages. Int Immunopharmacol 2002;2(11):1603-1611.
53. El-Mahmoudy A, Shimizu Y, Shiina T, Matsuyama H, El-Sayed M, Takewaki T. Successful abrogation by thymoquinone against induction of diabetes mellitus with streptozotocin via nitric oxide inhibitory mechanism. Int Immunopharmacol 2005;5(1):195-207.
54. Marsik P, Kokoska L, Landa P, Nepovim A, Soudek P, Vanek T. In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses. Planta Med 2005;71(8):739-742.
55. El-Dakhakhny M, Madi NJ, Lembert N, Ammon HP. Nigella sativa oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipoxygenase products in polymorphonuclear leukocytes from rats. J Ethnopharmacol 2002;81(2):161-164.
56. Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984;219(1):1-14.
57. Pigeolet E, Corbisier P, Houbion A, Lambert D, Michiels C, Raes M, Zachary MD, Remacle J. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev 1990;51(3):283-297.
58. Kruk I, Michalska T, Lichszteld K, Kladna A, Aboul-Enein HY. The effect of thymol and its derivatives on reactions generating reactive oxygen species. Chemosphere 2000;41(7):1059-1064.
59. Ismail M, Al-Naqeep G, Chan KW. Nigella sativa thymoquinone-rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats. Free Radic Biol Med 2009;48(5):664-672.